Financial Health Assessment: HUGH ALLAN (PROPERTIES) LIMITED

1. Financial Health Score: A-

Explanation: The patient exhibits excellent overall financial health, characterized by a robust asset base, very low leverage, and a strong heartbeat of positive equity. The minor deduction from a perfect score is due to a recent, though not alarming, reduction in cash reserves resulting from capital investments, and a latent deferred tax liability that will require management upon disposal of assets.

2. Key Vital Signs

• Blood Pressure (Leverage Ratio): Healthy and Low. Total liabilities stand at £167,311 against net assets of £2,902,294. This means liabilities represent less than 6% of total net worth. The company is experiencing no financial hypertension from debt.
• Pulse (Current Ratio): Strong. Current assets (£250,503) comfortably exceed current liabilities (£167,311), yielding a current ratio of approximately 1.5. The company has more than enough liquid resources to meet its short-term obligations without breaking a sweat.
• Weight (Asset Base): Heavy and Stable. The company carries £3,004,976 in tangible assets, overwhelmingly comprised of investment property valued at £3,002,880. This is a solid, muscular foundation for a property-based business.
• Respiration (Cash Flow): Steady, but slightly reduced. Cash at bank is £224,873, which is a healthy sum. However, this is down from a peak of £436,261 in 2023 and £429,085 in 2024. This "breathing rate" has slowed due to the acquisition of additional fixed assets (£317,445 in additions), which is a common and often healthy exertion for a property company.
• Medical History (Growth Trend): Excellent recovery and growth. Net assets have grown consistently year-over-year from £1,676,402 in 2016 to £2,902,294 in 2025. The patient has been building strength steadily over the last decade.

3. Diagnosis

The patient is suffering from no acute financial distress. In fact, it exhibits the symptoms of a highly secure, family-held property investment vehicle.

The primary engine of the business is property revaluation and retention, rather than high-volume operational turnover. The significant growth in shareholders' funds (from £1.67M to £2.90M over nine years) is largely driven by the appreciation of its investment property, supplemented by retained profits.

There is one latent condition that requires monitoring: a deferred tax liability of £185,874. This is essentially a "tax cholesterol" build-up resulting from the revaluation of properties. It is perfectly normal for a property company, but it represents a future tax bill that will come due if the properties are ever sold.

The recent reduction in cash reserves is not a symptom of illness, but rather a sign of reinvestment. The company used cash to fund £317,445 in capital additions, choosing to invest in its physical infrastructure rather than hoarding cash.

4. Recommendations

1. Maintain Cash Reserves (Hydration): While the drop in cash is explainable, it is important to keep liquid reserves at a level that comfortably covers administrative costs and unforeseen property maintenance. Ensure that rental income (if applicable) or cash flow is rebuilt to previous levels to maintain financial hydration.
2. Monitor the Latent Tax Condition: The £185,874 in deferred tax is a future obligation. The directors should ensure they have a long-term strategy for this—whether it be holding the properties until retirement (crystallizing the tax) or maintaining sufficient separate reserves to cover this liability when it eventually triggers.
3. Regular "Check-ups" on Valuations: The investment property was revalued by the director, H Allan. While permissible for small entities under FRS 102, periodic independent valuations act as a "second opinion" that can validate the health of the asset base and provide comfort to stakeholders.
4. Consider Strategic Leverage (Vitamin Supplements): With such low leverage, the company is extremely safe but may be missing out on growth opportunities. While debt carries risk, a small, manageable level of long-term financing could act as a vitamin supplement to accelerate portfolio growth, especially given the strong asset base available as collateral.